Marketplace
  Articles
Business Listings
  Login
  Register
Obesity Drugs Are a Potential $100 Billion Opportunity by 2030, Goldman Sachs Analysts Say
    Posted on 10/17/2023
Obesity Drugs Are a Potential $100 Billion Opportunity by 2030, Goldman Sachs Analysts Say
Comments( 0 )